Lung function monitoring in patients with duchenne muscular dystrophy on steroid therapy

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  MacHado, Darlene L ^a   Silva, Elaine C ^a   Resende, Maria B D ^a   Carvalho, Celso R F ^a   Zanoteli, Edmar ^a,b   Reed, Umbertina C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b AACD   (Brazil)

Author keywords

Duchenne muscular dystrophy; Myopathies; Respiratory function tests; Steroids; Vital forced capacity

Indexed keywords

ANTIINFLAMMATORY AGENT; DEFLAZACORT; PREDNISOLONE; PREGNANE DERIVATIVE;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHILD; DRUG EFFECT; DUCHENNE MUSCULAR DYSTROPHY; FORCED EXPIRATORY VOLUME; HUMAN; LUNG; LUNG FUNCTION TEST; MALE; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; TREATMENT OUTCOME; VITAL CAPACITY;

ADOLESCENT; ANALYSIS OF VARIANCE; ANTI-INFLAMMATORY AGENTS; CHILD; CHILD, PRESCHOOL; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MUSCULAR DYSTROPHY, DUCHENNE; PREDNISOLONE; PREGNENEDIONES; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME; VITAL CAPACITY; YOUNG ADULT;

EID: 84864816432     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-435     Document Type: Article

References (23)

1. DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C, Lancet Neurol 2010 9 77 93 10.1016/S1474-4422(09)70271-6 19945913
2. DMD Care Considerations Working Group. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Bushby K, Finkel R, Birnkrant DJ, Case LE, Clemens PR, Cripe L, Kaul A, Kinnett K, McDonald C, Pandya S, Poysky J, Shapiro F, Tomezsko J, Constantin C, Lancet Neurol 2010 9 177 189 10.1016/S1474-4422(09)70272-8 19945914
3. Practical problems in the respiratory care of patients with muscular dystrophy. Smith PM, Calverley PM, Edwards RH, Evans GA, Campbell EJ, N Engl J Med 1987 316 1197 1205 10.1056/NEJM198705073161906 3553943
4. Sleep and neuromuscular disorders in children. Alves SC, Resende MBD, Skomro RP, Sousa JFB, Reed UC, Sleep Med Rev 2009 13 133 148 10.1016/j.smrv.2008.02.002 18534877
5. Pulmonary function in progressive muscular dystrophy. Hapke EJ, Meek JC, Jacobs J, Chest 1972 61 41 47 10.1378/chest.61.1.41 5049500
6. Lung function in children with Duchennes muscular dystrophy. Tangsrud SE, Petersen IL, Carlsen KCL, Carlsen KH, Respir Med 2001 95 898 903 10.1053/rmed.2001.1177 11716204
7. Respiratory Function in muscular dystrophies. Rideau Y, Jankowski LW, Grellet J, Muscle Nerve 1981 4 155 164 10.1002/mus.880040213 7207506
8. Prognosis of progressive muscular dystrophy in children. Rideau Y, Analysis of early and exact criteria. Union Med Can 1977 106 874 882
9. Profiles of neuromuscular diseases. Duchenne muscular dystrophy. McDonald CM, Abresch RT, Carter GT, Fowler WM, Johnson ER, Kilmer DD, Sigford BJ, Am J Phys Med Rehabil 1995 74 Suppl 5 70 S92 7576424
10. Clinical implications of maximal respiratory pressure determinations for individuals with Duchenne muscular dystrophy. Hahn AH, Bach JR, Delaubier A, Irani AR, Guillou C, Rideau Y, Arch Phys Med Rehabilit 1997 78 1 6 10.1016/S0003-9993(97)90001-0
11. Ventilatory parameters and maximal respiratory pressure changes with age in Duchenne Muscular Dystrophy patients. Gayraud J, Ramonatxo M, Rivier F, Humberclaude V, Petrof B, Matecki S, Pediatr Pulmonol 2010 45 552 559 20503279
12. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy. Fenichel GM, Florence MD, Pestronk A, Mendell JR, Moxley RT, Griggs RC, Brooke MH, Miller JP, Robison J, King W, Neurology 1991 41 1874 1877 10.1212/WNL.41.12.1874 1745340
13. High dose weekly oral predinisone improves strength in boys with Duchenne muscular dystrophy. Connolly AM, Schierbecker J, Renna R, Florence J, Neuromuscul Disord 2002 12 917 925 10.1016/S0960-8966(02)00180-3 12467746
14. Costicosteroid treatment and functional improvement in Duchenne muscular dystrophy: long term effect. Balaban B, Matthews DJ, Clayton GH, Carry T, Am J Phys Med Rehabil 2005 84 843 850 10.1097/01.phm.0000184156.98671.d0 16244521
15. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Biggar WD, Harris VA, Eliasoph L, Alman B, Neuromuscul Disord 2006 16 249 255 10.1016/j.nmd.2006.01.010 16545568
16. Comparison of motor strength and function in patients with Duchenne muscular dystrophy with or without steroid therapy. Parreira SL, Resende MB, Zanoteli E, Carvalho MS, Marie SK, Reed UC, Arq Neuropsiquiatr 2010 68 683 688 10.1590/S0004-282X2010000500002 21049175
17. American thoracic society/european respiratory society: statement on respiratory muscle testing. ATS/ERS, Am J Respir Crit Care Med 2002 166 518 624 12186831
18. The maximal expiratory flow-volume curve. Normal standards, variability, and effects of age. Knudson RJ, Slatin RC, Lebowitz MD, Burrows B, Am Rev Respir Dis 1976 113 587 600 1267262
19. Steroid Treatment and the development of scoliosis in males with Duchenne muscular dystrophy. Alman BA, Raza SN, Biggar WD, J Bone Joint Surg Am 2004 86 519 524 14996877
20. Effect of long-term steroids on cough efficiency and respiratory muscle strength in patients with Duchenne muscular dystrophy. Daftary AS, Crisanti M, Kalra M, Wong B, Amin R, Pediatrics 2007 119 2 320 e324 10.1542/peds.2006-1400 17272595
21. Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Mazzone E, Vasco G, Sormani MP, Torrente Y, Berardinelli A, Messina S, D'Amico A, Doglio L, Politano L, Cavallaro F, Frosini S, Bello L, Bonfiglio S, Zucchini E, De Sanctis R, Scutifero M, Bianco F, Rossi F, Motta MC, Sacco A, Donati MA, Mongini T, Pini A, Battini R, Pegoraro E, Pane M, Gasperini S, Previtali S, Napolitano S, Martinelli D, Bruno C, Vita G, Comi G, Bertini E, Mercuri E, Neurology 2011 77 3 250 256 10.1212/WNL. 0b013e318225ab2e 21734183
22. Air stacking and chest compression increase peak cough flow in patients with Duchenne muscular dystrophy. Brito MF, Moreira GA, Hallinam MP, Tufik S, J Bras Pneumol 2009 39 973 979
23. Lung insuflation by glossopharyngeal breathing and air stacking in Duchenne Muscular Dystrophy. Bach JR, Bianchi C, Vidigal-Lopes M, Turi S, Felisari G, Am J Phys Med Rehabil 2007 86 295 300 10.1097/PHM.0b013e318038d1ce 17413542